Christine Gu

425 total citations
19 papers, 238 citations indexed

About

Christine Gu is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Christine Gu has authored 19 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Hematology. Recurrent topics in Christine Gu's work include Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Christine Gu is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Christine Gu collaborates with scholars based in United States, Greece and United Kingdom. Christine Gu's co-authors include Jason Gruenhagen, Peter Yehl, Colin D. Medley, Nik P. Chetwyn, Kelly Zhang, Yi Li, Julia Gavrilyuk, Yi Li, Monette Aujay and Hetal Sarvaiya and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Cancer Research.

In The Last Decade

Christine Gu

18 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Gu United States 9 118 112 99 41 32 19 238
Claudia M. Jochheim United States 9 163 1.4× 83 0.7× 124 1.3× 28 0.7× 17 0.5× 11 293
Tracey Colpitts United States 9 192 1.6× 75 0.7× 37 0.4× 36 0.9× 21 0.7× 14 322
Dean Messing United States 10 139 1.2× 55 0.5× 18 0.2× 62 1.5× 16 0.5× 14 281
Ewa Surmiak Poland 11 205 1.7× 191 1.7× 34 0.3× 126 3.1× 8 0.3× 22 375
Andreea D. Stuparu United States 10 102 0.9× 111 1.0× 217 2.2× 43 1.0× 41 1.3× 14 372
Adrian D. Hobson United States 9 130 1.1× 116 1.0× 67 0.7× 204 5.0× 9 0.3× 25 385
Teja Kalidindi United States 8 67 0.6× 75 0.7× 128 1.3× 11 0.3× 13 0.4× 21 255
Zohreh Noaparast Iran 14 168 1.4× 125 1.1× 200 2.0× 64 1.6× 3 0.1× 25 406
Yongzhi Gao Netherlands 8 192 1.6× 153 1.4× 23 0.2× 64 1.6× 6 0.2× 10 376

Countries citing papers authored by Christine Gu

Since Specialization
Citations

This map shows the geographic impact of Christine Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Gu more than expected).

Fields of papers citing papers by Christine Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Gu. The network helps show where Christine Gu may publish in the future.

Co-authorship network of co-authors of Christine Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Gu. A scholar is included among the top collaborators of Christine Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Gu. Christine Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ball, Somedeb, Michael Byrne, Melissa A. Fischer, et al.. (2025). AML-117: A Phase 1b Study of Selinexor and Venetoclax in Patients With Relapsed or Refractory Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 25. S402–S403.
2.
Michelson, Glenn, et al.. (2024). AML-553 Revival of the PLK1 Inhibitor Volasertib in Relapsed/Refractory Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 24. S320–S321. 1 indexed citations
3.
Ball, Somedeb, Michael Byrne, Melissa A. Fischer, et al.. (2024). Application of a Phenotype-Based Predictive Analytic in a Phase Ib Study of Selinexor and Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia. Blood. 144(Supplement 1). 6012–6012. 1 indexed citations
4.
Stieglitz, Elliot, Christine Gu, Michelle Richardson, et al.. (2023). Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay. JCO Precision Oncology. 7(7). e2300302–e2300302. 1 indexed citations
5.
Ladror, Daniel T., et al.. (2023). Preclinical Characterization of Catabolic Pathways and Metabolism of ABBV-011, a Novel Calicheamicin-Based SEZ6-Targeting Antibody-Drug Conjugate. Drug Metabolism and Disposition. 52(2). 135–142. 4 indexed citations
6.
Wagner, Joseph, Markus D. Lacher, Christine Gu, Christopher Leonardi, & Gabriel N. Mannis. (2023). A Phase 2 Study with Volasertib for Ven-HMA Relapsed/Refractory Acute Myeloid Leukemia Patients Guided By a Predictive Precision Medicine Platform. Blood. 142(Supplement 1). 5952–5952. 1 indexed citations
7.
Jacoby, Meagan A., John S. Welch, Peter Westervelt, et al.. (2023). Abstract 4342: Predictive precision medicine platform accurately predicts individual patient response to AML treatments to maximize outcomes. Cancer Research. 83(7_Supplement). 4342–4342. 2 indexed citations
8.
Gavrilyuk, Julia, Xi Zhao, Hetal Sarvaiya, et al.. (2022). ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors. Molecular Cancer Therapeutics. 21(6). 986–998. 32 indexed citations
9.
Zhang, Chenghong, Sungjoon Cho, José G. Napolitano, et al.. (2022). Elucidating the structure and cytochrome P450-mediated mechanism for novel metabolites of GDC-0575 in rats. Xenobiotica. 52(3). 219–228. 2 indexed citations
10.
Strachan, Debbie, Christine Gu, Ryosuke Kita, et al.. (2022). Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML. Cancers. 14(24). 6240–6240. 6 indexed citations
11.
Nicolaou, K. C., Sanjay Kumar, Ananda Rao Podilapu, et al.. (2021). Design, Synthesis, and Biological Investigation of Thailanstatin A and Spliceostatin D Analogues Containing Tetrahydropyran, Tetrahydrooxazine, and Fluorinated Structural Motifs. The Journal of Organic Chemistry. 86(3). 2499–2521. 4 indexed citations
12.
Holte, Dane, Joseph P. Lyssikatos, Joseph Sandoval, et al.. (2020). Evaluation of PNU-159682 antibody drug conjugates (ADCs). Bioorganic & Medicinal Chemistry Letters. 30(24). 127640–127640. 15 indexed citations
13.
Nicolaou, K. C., Ruofan Li, Zhaoyong Lu, et al.. (2020). Synthesis and Biological Evaluation of Shishijimicin A-Type Linker-Drugs and Antibody–Drug Conjugates. Journal of the American Chemical Society. 142(29). 12890–12899. 13 indexed citations
14.
Nicolaou, K. C., Yogesh G. Shelke, Balu D. Dherange, et al.. (2020). Design, Synthesis, and Biological Investigation of Epothilone B Analogues Featuring Lactone, Lactam, and Carbocyclic Macrocycles, Epoxide, Aziridine, and 1,1-Difluorocyclopropane and Other Fluorine Residues. The Journal of Organic Chemistry. 85(5). 2865–2917. 19 indexed citations
15.
Nicolaou, K. C., Parthasarathi Subramanian, Balu D. Dherange, et al.. (2020). Streamlined Symmetrical Total Synthesis of Disorazole B1 and Design, Synthesis, and Biological Investigation of Disorazole Analogues. Journal of the American Chemical Society. 142(36). 15476–15487. 12 indexed citations
16.
Li, Yi, Christine Gu, Jason Gruenhagen, et al.. (2016). An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates. mAbs. 8(4). 698–705. 33 indexed citations
17.
Li, Yi, Christine Gu, Jason Gruenhagen, et al.. (2015). A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates. Journal of Chromatography A. 1393. 81–88. 60 indexed citations
18.
Chen, Tao, Dian Su, Jason Gruenhagen, et al.. (2015). Chemical de-conjugation for investigating the stability of small molecule drugs in antibody-drug conjugates. Journal of Pharmaceutical and Biomedical Analysis. 117. 304–310. 22 indexed citations
19.
Stumpf, Andreas, Brian Wong, Rémy Angelaud, et al.. (2015). Development of an Expedient Process for the Multi-Kilogram Synthesis of Chk1 Inhibitor GDC-0425. Organic Process Research & Development. 19(6). 661–672. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia M. Jochheim Breakdown of academic impact, for papers by Tracey Colpitts Breakdown of academic impact, for papers by Dean Messing Breakdown of academic impact, for papers by Ewa Surmiak Breakdown of academic impact, for papers by Andreea D. Stuparu Breakdown of academic impact, for papers by Adrian D. Hobson Breakdown of academic impact, for papers by Teja Kalidindi Breakdown of academic impact, for papers by Zohreh Noaparast Breakdown of academic impact, for papers by Yongzhi Gao
Rankless by CCL
2026